第一单位:
Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland. jani.huuhtanen@helsinki.fi.;Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. jani.huuhtanen@helsinki.fi.;Department of Computer Science, Aalto University, Espoo, Finland. jani.huuhtanen@helsinki.fi.;iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland. jani.huuhtanen@helsinki.fi.
作者:
Jani,Huuhtanen [1]
;
Shady,Adnan-Awad [2]
;
Jason,Theodoropoulos [3]
;
Sofia,Forstén [3]
;
Rebecca,Warfvinge [4]
;
Olli,Dufva [3]
;
Jonas,Bouhlal [3]
;
Parashar,Dhapola [4]
;
Hanna,Duàn [3]
;
Essi,Laajala [3]
;
Tiina,Kasanen [3]
;
Jay,Klievink [3]
;
Mette,Ilander [5]
;
Taina,Jaatinen [6]
;
Ulla,Olsson-Strömberg [7]
;
Henrik,Hjorth-Hansen [8]
;
Andreas,Burchert [9]
;
Göran,Karlsson [4]
;
Anna,Kreutzman [5]
;
Harri,Lähdesmäki [10]
;
Satu,Mustjoki [11]
作者单位:
Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland. jani.huuhtanen@helsinki.fi.;Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. jani.huuhtanen@helsinki.fi.;Department of Computer Science, Aalto University, Espoo, Finland. jani.huuhtanen@helsinki.fi.;iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland. jani.huuhtanen@helsinki.fi.
[1]
Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.;Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.;iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.;Foundation for the Finnish Cancer Institute, Helsinki, Finland.
[2]
Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.;Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.;iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
[3]
Division of Molecular Hematology, Lund Stem Cell Center, Lund University, Lund, Sweden.
[4]
Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.;Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
[5]
Histocompatibility Testing Laboratory, Finnish Red Cross Blood Service, Helsinki, Finland.
[6]
Department of Medical Sciences, Uppsala University and Hematology Section, Uppsala University Hospital, Uppsala, Sweden.
[7]
Department of Hematology, St. Olavs Hospital, Trondheim, Norway.;Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
[8]
Department of Hematology, Oncology and Immunology, Philipps University Marburg, and University Medical Center Giessen and Marburg, Marburg, Germany.
[9]
Department of Computer Science, Aalto University, Espoo, Finland.
[10]
Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland. satu.mustjoki@helsinki.fi.;Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. satu.mustjoki@helsinki.fi.;iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland. satu.mustjoki@helsinki.fi.
[11]
DOI
10.1038/s41375-023-02074-w
PMID
37919606
发布时间
2024-06-27